Trial Profile
Be-PrEP-ared: HIV prevention with Pre-exposure prophylaxis – a demonstration project in high risk men having sex with men in Belgium
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Jul 2018
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms Be-PrEP-ared
- 29 Jun 2018 Status changed from recruiting to completed.
- 28 Jul 2015 New trial record